Mumbai: Mumbai-based Inventys Research Firm has raised Rs 225 crore by non-public placement from Plutus Wealth Management and Pantomath Capital Management.
Plutus Wealth Administration dedicated Rs 225 crores of major infusion into the corporate. On the similar time, India Inflection Alternative Fund, managed by Pantomath Capital Administration, picks up the secondary spherical supplied by sure current shareholders of the corporate.
Inventys is a research-driven specialty chemical producer specializing in customized synthesis and manufacturing (CSM). The corporate has a diversified product portfolio comprising Superior Intermediates & Actives utilized in Crop-Safety and Pharmaceutical purposes and different specialty segments.
Pantomath Capital Advisors Non-public Restricted acted as the only funding banker for the transaction.
Uncover the tales of your curiosity
Keep on high of technology and startup news that issues. Subscribe to our every day publication for the most recent and must-read tech information, delivered straight to your inbox.
